HONG KONG, March 25, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that it has received clearance from the Center for Drug Evaluation (CDE) of China’s National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results